Pura Vida Investments’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Pura Vida Investments’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-90,000	Closed	-$2.36M	–	192
2022 Q4	$2.36M	Buy	+90,000	New	+$1.99M	0.12%	117
2022 Q2	–	Sell	-85,236	Closed	-$1.39M	–	290
2022 Q1	$1.39M	Sell	85,236 -5,005	-6%	-$68K	0.05%	174
2021 Q4	$1.47M	Buy	90,241 +17,543	+24%	+$250K	0.05%	161
2021 Q3	$928K	Sell	72,698 -1,279	-2%	-$16.8K	0.03%	225
2021 Q2	$1.04M	Buy	+73,977	New	+$1.18M	0.03%	179

Other funds holding KDNY

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Pura Vida Investments's KDNY Position: Q1 2023 in Review

Pura Vida Investments sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q1 2023, closing a stake of 90,000 shares — an estimated $2.36M sold.

Pura Vida Investments first reported a position in KDNY in Q2 2021 and held it in 5 quarters. The position peaked at $2.36M in Q4 2022. 157 funds tracked by Wall St. Rank hold KDNY as of Q1 2023.

Pura Vida Investments reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Pura Vida Investments sold 90,000 Chinook Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $2.36M.
Pura Vida Investments first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
Pura Vida Investments's Chinook Therapeutics, Inc. Common Stock position peaked at $2.36M in Q4 2022.
157 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.